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INFLUENCE OF THE ENVIRONMENT ON
ASYMPTOMATIC HUMAN DISEASE
HARRY P. WARD, M.D.*
HE CONCEPT of altering the incidence and the effect of a disease
by a change in the external or internal environment of the pa-
tient is well established. The incidence of insect-borne disease
(e.g., malaria, yellow fever) has been reduced by the elimination of
the mosquito vector, a change of the external environment. The
survival of patients with pneumonia has been increased markedly by
the use of antibiotics (a change of the internal environment). A rela-
tively recent medical concept is the unmasking of a disease heretofore
asymptomatic or "occult," as a result of a change in the environment.
The disease may be either inherited or acquired, but in both cases, the
patient and the physician are unaware of an underlying abnormality
until a specific environmental change produces overt symptoms.
INFLUENCE OF ENVIRONMENT ON INHERITED ABNORMALITIES
The inheritance of man is determined by the information that is
carried on forty-six chromosomes located in the nucleus of each cell.
Each chromosome consists of thousands of genes that have been inter-
mixed during the evolution of man through a variety of mechanisms:
(a) mutation of a gene, which is a change in a specific inherited charac-
ter; (b) recombination of chromosomes in which separate chromosome
strands are exchanged; and (c) random distribution of chromosomes
in reproduction. The consequence of these alterations is a human
that is biochemically unique, yet amazingly similar to other members
of his species.
* DR. WARD is Chief of Medical Service at the Veterans Administration Hospital in
Denver, Colorado. He is an Associate Professor of Medicine at the University of Colorado
School of Medicine. DR. WARD received his B.A., magna cum laude, from Princeton
University, his M.D. from the University of Colorado School of Medicine, and his M.S.
from the University of Minnesota. He is a Diplomate of the American Board of Internal
Medicine, a Fellow of the American College of Physicians, and a member of the American
Society for Nuclear Medicine, American Society of Hematology and the American Fed-
eration for Clinical Research. DR. WARD has written fifteen articles which have appeared in
various medical journals.
ENVIRONMENT AND ASYMPTOMATIC DISEASE
The expression of each inherited characteristic is modified by other
inherited characteristics and by the environment. For example, the
inheritance of high intelligence is not expressed if the patient also
inherits the gene for phenylketonuria, a disease that is characterized by
mental deficiency. Therefore, abnormalities in the inherited constitu-
tion of an individual have a great variability in the degree of ex-
pression:
(a) Asymptomatic and without consequences. These inherited ab-
normalities are without known human disease and are laboratory
curiosities (e.g., the inability to taste thiourea compounds,
hereditary webbing of toes).
(b) Symptomatic to a moderate or lethal degree. Such inherited ab-
normalities are overtly symptomatic during the life span of the
patient. The inherited disease may be expressed at infancy (e.g.,
phenylketonuria, mongolism), or as an adult (e.g., gout, diabetes
mellitus).
(c) Asymptomatic except for environmental alterations. Changes in
the internal or external environment result in the overt expres-
sion of a previously asymptomatic inherited disease, occasionally
resulting in death. This category represents the largest and,
unfortunately, the most poorly understood group.
ALTERATION OF INTERNAL ENVIRONMENT
The term "pharmacogenetics" was introduced by Vogel in 19592
to indicate a study of genetically determined variance which is re-
vealed by an altered response to specific drugs. A classical example of
pharmacogenetics is the severe hemolytic anemia induced in certain
patients by drugs. Destruction of red blood cells, hemolytic anemia, by
drugs is a well-known clinical event that has been observed by physi-
cians for centuries. Since drugs are used in patients suffering from
disease, some of which can cause anemia, the importance of the drug,
as a cause of anemia, was not appreciated until the 1940's. During
World War II, a large program for the testing of antimalarial drugs
in human volunteers was launched. These volunteers were without
1 STANBURY, WYNGAARDEN & FREDRICKSON, THE METABOLIC BASIS OF INHERITED DISEASE
3 (2d ed. 1966).
2 Vogel, Moderne Probleme der Humangenetik, 12 ERGEBN. INN. MED. KINDERtlETLK
52 (1959).
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disease and it was noted that in some of the patients an acute hemolytic
anemia occurred.' Subsequent studies of the biochemistry of the sensi-
tive red blood cells have shown that the major abnormality is a de-
ficiency of an enzyme in sugar metabolism called glucose 6 phosphate
dehydrogenase (G6PD). 4 A deficiency of this enzyme results in a cell
that can not maintain itself in an environment of certain drugs (anti-
malarials, sulfonamides, etc.). Certain agents such as aspirin can
induce hemolysis of G6PD-deficient cells, but only in huge doses. The
patient who is sensitive to this type of drug reaction has an entirely
normal life expectancy unless exposed to an ordinarily harmless drug.
The erythrocyte abnormality is asymptomatic or "occult," and is only
expressed when the internal environment is altered.
A similar abnormality that has been reported recently is an inherited
deficiency of pseudocholinesterase, an enzyme in the body that is
important in nerve conduction.5 In 1952, a drug, Suxamethonium, was
introduced as a rapid acting, short duration muscle relaxant to be
used during surgery. Several patients exhibited a marked sensitivity
to the drug. Normally, the drug causes muscle relaxation of two to
three minutes; in a few patients, a marked sensitivity to the drug was
found with extreme muscle relaxation and associated lack of respira-
tion (apnea) for as long as three hours. This unusual reaction is the
result of a deficiency of pseudocholinesterase, an inherited enzyme. A
number of families with this abnormality have been studied and the
patients are entirely healthy with a normal life expectancy, unless ex-
posed to an ordinarily harmless drug during the course of surgery.
Physicians always have recognized a rare, "idiosyncratic" reaction
that can occur with drugs. An idiosyncratic reaction is an unusual
reaction that is totally dissimilar to the expected pharmacologic reac-
tion of the drug. A typical example of this type of reaction is illustrated
by the drug Chloramphenicol (Chloromycetin'). This drug is an
effective antibiotic and has been used in millions of patients for infec-
tious diseases. The pharmacologic property of the antibiotic is to kill
bacteria by interference with the metabolism of the infecting organism.
3 Dern, Weinstein, LeRoy, Talmage & Alving, The Hemolytic Effect of Primaquine,
43 J. LAB. CLIN. MED. 303 (1954).
4 Beutler, Glucose-6-Phosphate-Dehyrogenase Deficiency and Nonspherocytic Congenital
Hemolytic Anemia, 2 SEm. N HEMAT. 91 (1965).
5 Lehmann & Liddell, Pseudocholinesterase Deficiency and Some Other Pharmacogenetic
Disorders, in Trt METABO IC BASIS OF INHERITED DISEASE 1356 (2d ed. 1966).
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The normal cells of the body are influenced to a slight degree by the
drug and a mild depression of the normal red cell and white cell count
occurs.' Rarely, an idiosyncratic reaction occurs and all of the bone
marrow cells of the patient are destroyed, a condition called aplastic
anemia. This condition has a mortality of nearly one hundred per cent
and Chloramphenicol is currently the major recognized cause of
aplastic anemia in the United States. The occurrence of aplastic anemia
in these patients is not related to the dosage of Chloromycetin or the
condition of the patient at the time the drug is given. In addition,
there is no way for the physician to identify the patient in whom this
dread reaction will occur. The reaction has an estimated frequency
of one in 10,000 patients; a frequency similar to the frequency of
phenylketonuria, an inherited abnormality. The rarity of the idio-
syncratic reaction suggests an inherited abnormality in the patient
is made manifest by the drug.
With the discovery of new drugs for human disease, many pharma-
cogenetic abnormalities will be identified. The problem of causation of
disease is difficult to evaluate when the reaction to the drug is a
manifestation of a pre-existing inherited disease. Informed consent from
patients for the use of all drugs that may cause idiosyncratic reactions
would place an impossible burden on the physician and the patient,
would seriously interfere with medical practice, and would not signif-
icantly reduce the frequency of this type of reaction.
ALTERATION OF EXTERNAL ENVIRONMENT
The role of the external environment in manifesting an inherited
disease is graphically illustrated by the role of trauma in the patient
with hemophilia, an inherited disease that causes bleeding. The role
of the environment in this abnormality was recognized as long ago as
the sixth century A.D. when it was stated in the Tract Yebamoth of
the Babylonian Talmud that all boys whose brothers had bled follow-
ing circumcision were exempted from this rite. Today, the inherited
pattern of this disease is well established. An abnormal gene is carried
on the sex chromosome and is transferred from the asymptomatic,
carrier mother to fifty per cent of her sons. The affected male can
6 Ward, The Effect of Chloramphenicol on RNA and Hemesynthesis in Bone Marrow
Cultures, 68 J. LAB. CLIN. MED. 400 (1966).
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expect a long-term survival unless the external environment (i.e.,
trauma) supervenes.
Another interesting example of the influence of the external environ-
ment on an inherited disease is illustrated by patients with an abnormal
hemoglobin, the protein in red cells that carries oxygen. The structure
of hemoglobin is inherited and the majority of the white race carries
the same form of hemoglobin, called hemoglobin A. In certain areas of
Africa, a different form of hemoglobin called hemoglobin S (sickle
hemoglobin) is carried in the population. This type of hemoglobin
probably has survived the influence of natural selection because a red
cell with hemoglobin S is more resistant to infestation with malaria,
an obvious survival advantage in Africa. A patient with one hundred
per cent hemoglobin S, a homozygous S inheritance, has a shortened
natural survival because of the propensity of red cells with this type of
hemoglobin to spontaneously adopt a "sickle" shape instead of the
normal round form. The sickled red cells aggregate in small clots,
blocking circulation to vital organs, and, eventually, causing death.
Individuals with the heterozygote or carrier form of sickle cell disease
have fifty per cent S hemoglobin and fifty per cent A hemoglobin. The
amount of normal A hemoglobin is sufficient to prevent spontaneous
sickling and a normal life survival is expected. In World War II, many
Negro troops transported in non-pressurized airplanes had the sudden
onset of severe, diffuse pain, anemia, and occasionally, death. An inten-
sive study of this problem showed that these soldiers had heterozygote
sickle cell disease, the asymptomatic trait. Further investigation estab-
lished that low oxygen tension (e.g., high altitude) causes red cells
with fifty per cent S hemoglobin to "sickle." The asymptomatic,
occult inherited disease becomes symptomatic and a threat to life by a
change in the external environment. The following case is an example
of this problem:
A 34-year-old Negro was admitted to Colorado General Hospital for a two-hour
history of severe, left upper abdominal pain and shortness of breath that occurred
at the top of Pikes Peak, an altitude of approximately 14,000 feet. The patient had
been in excellent health all of his life and had gained national fame as a high
school athlete, an All-American football player, a national record holder in track
and field events, and a professional football player. He was currently em-
ployed by a major corporation as a sales representative and was in Colorado for a
sales meeting at the time of his trip to Pikes Peak. On admission, the physical
examination was remarkable for severe, left upper abdominal pain and splinting of
the left chest with respirations. Laboratory evaluation showed a mild anemia with
obvious sickle-cell heterozygote state. Subsequent studies demonstrated that this
[Vol. XVIII: 644
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patient had suffered an infarction or a blood clot in the spleen and had a mild left
lower lung pneumonia because of his inability to take a deep breath due to severe
splenic pain. The patient improved during the following seven days and was dis-
charged from the hospital without further therapy. He was advised to avoid environ-
ments with a low oxygen tension because of the sickle cell trait.
The influence of the environment on asymptomatic inherited mental
diseases is speculative at this time. A possible link between an abnormal
chromosome number and criminal behavior was suggested in 1965
when an XYY chromosome complement was detected in nearly four per
cent of the inmates at a maximum security prison in Scotland. Several
recent chromosome surveys of newborns indicate that the XYY karo-
type may occur in as many as one in three hundred males. If this high
frequency is confirmed by additional studies, the role of the environment
in the cause of criminal behavior and the role of a protective environ-
ment as a therapy for the genetically-fated criminal must be re-eval-
uated by society.
INFLUENCE OF ENVIRONMENT ON ACQUIRED DISEASE
The natural history of acquired disease has a predictable pattern.
All of us have observed the syndrome of the "flu" with a short,
asymptomatic incubation period of three to seven days; initial, sharply
demarcated symptoms of fever, chills and stuffy nose; a symptomatic
duration of three days; and complete recovery. The majority of human
disease follows this simple pattern but with a greatly expanded scale.
The asymptomatic or incubation period may be measured in decades
instead of days and resembles the hidden portion of an iceberg. Recent
evidence suggests that even leukemia 7 and cancer8 may have a long
asymptomatic period. The ability of the physician to diagnose a disease
during the incubation period is poor primarily because of the limita-
tions of current diagnostic methodology and the functional reserve
capacity of all organs of the body.
Methods of diagnosis in human disease have advanced rapidly in
the past fifty years. Although the physician is still highly dependent
upon a history and a physical examination of the patient, a large
armamentarium of blood, urine, X-ray and radioisotope methodology
7 Ward & Block, Myeloid Metaplasia-A Reevaluation [to be published in SYMPOSIUM
ON MYELOPROLIFERATIVE DISORDERS OF ANIMALS AND MAN (Battelle Memorial Institute)].
8 Garland, Coulson & Wollin, The Rate of Growth and Apparent Duration oj Untreated
Primary Bronchial Carcinoma, 16 CANcER 694 (1963).
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is available. The value of a routine yearly physical examination is
based on the ability of medical science to diagnose disease in the
asymptomatic period. Advances have been made, but a normal physical
examination and laboratory evaluation does not exclude significant
disease. Unfortunately, a patient may have a heart attack within
minutes or days of a normal electrocardiogram. This does not indicate
failure of the electrocardiogram, but only demonstrates that the elec-
trical impulses recorded by the electrocardiogram are normal until
the death of heart muscle. The process that causes the death of heart
muscle is atherosclerosis (hardening of the arteries), a process that
takes decades. The electrocardiogram is unable to detect the progres-
sion of atherosclerosis and only detects the end result, a myocardial
infarction. A similar limitation in diagnostic methodology is demon-
strated by reliance on the chest X-ray to exclude lung disease. An
abnormality in the chest must reach a significant size before it can be
separated from the mottled background of the normal lung. Studies
in several medical centers have shown that cancer of the lung may
exist for as long as twelve years before the diagnosis can be established
in the chest X-ray.9
io 75- The relationship between the total
function of an organ and the measure-
= 50 ment of a common metabolic product
of the organ. For example, kidney func-
S25. tion and level of urea in the blood; liver
function and level of bilirubin in the
blood.
I N 2N 3N 4N
METABOLIC MEASUREMENT
(N - NORMAL)
The functional reserve capacity of an organ is a fundamental,
biological feature of all organs of the body. The relationship is hyper-
bolic. An analysis of the properties of a hyperbolic function shows
that organ function can be reduced to greater than fifty per cent
of normal before standard methods of measurement detect a signif-
icant abnormality. This has obvious importance in survival; an
individual can lose one kidney (reduction of 50% of kidney organ
9 Supra note 8.
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function) and have a normal urea (a metabolic measurement of the
kidney). This biological law forms the basis for renal transplantation.
The donor, who is left with one kidney, and the recipient, who receives
one kidney, are entirely normal without symptoms of uremia.
The same hyperbolic relationship is found with the heart, lung, or
liver. A serious degree of impairment, as much as seventy per cent in
some organs, can exist without symptoms in the patient and without
routine laboratory measurements indicating a disease. When the func-
tional reserve of an organ has reached a critical level, minor changes in
the internal or external environment that would be insignificant to a
normal organ may result in overt clinical manifestations of the occult
disease.
ALTERATION OF INTERNAL ENVIRONMENT
A change in the internal environment in a patient with asympto-
matic acquired disease may lead to explosive and sometimes fatal
reactions. The reactions can be divided into two major categories: (1)
increased sensitivity of a deceased target organ to drugs, and (2) fail-
ure of normal breakdown or excretion of drugs due to disease in a non-
target organ.
A diseased organ frequently has an increased sensitivity to the action
of a drug. The increased activity may represent increased entry of the
drug into the diseased cell or accentuation of the action of the drug on
a biochemical process within the diseased cell. The heightened effect
of the drug occurs at a dosage level that is easily and safely tolerated
by a normal cell or organ. A common example of this problem is
illustrated by the drug digitalis. This drug has been used for over one
hundred fifty years in the treatment of congestive heart failure and
remains today the most effective method of therapy for this common
disease. A standard dosage of therapy has been determined in medical
practice that provides a wide safety margin, the difference between a
toxic level and a therapeutic level. Patients with certain forms of heart
disease (e.g., primary myocardiopathy, cor pulmonale) are exquisitely
sensitive to the effects of this drug and the usual drug dosage may
cause a toxic level and result in death.
The majority of drugs used in medical practice are metabolized or
excreted by the liver or kidney. These drugs may be used for a
1969]
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target organ elsewhere in the body, but because the level of the drug
depends upon its metabolism within the body, a toxic level of the drug
results from disease in the nontarget organ. The antibiotics strepto-
mycin, kanamycin and polymyxin are excreted by the kidneys and in
normal patients these antibiotics are virtually nondetectable in the
blood four hours after injection. When the kidney is diseased, the ex-
cretion of these drugs is impaired and a significant level of strepto-
mycin may be measured in the blood twenty-five to thirty hours after
injection.1" The elevated level of streptomycin is toxic and side effects
such as ototoxicity (deafness) can occur. Unless the physician is aware
of significant renal disease, a standard therapeutic dose level in this
type of patient is a toxic level.
A similar problem is encountered when using a drug that is metabo-
lized by the liver in a patient with asymptomatic occult liver disease.
The liver is the major site of metabolism of several of the barbiturates.
A diseased liver, but a liver not producing symptoms, is unable to ex-
crete barbiturates and a high level is produced by an innocuous dosage.
A barbiturate sleeping pill given to a patient with liver disease may re-
sult in a state of unconsciousness for several days and cause death.
A recent group of drug problems has been described that represents
cross interference between two drugs. This problem has been recog-
nized previously but an explanation has not been apparent. Recently,
a large number of drugs have been found to stimulate their own metab-
olism or the metabolism of other compounds. The stimulation of metab-
olism represents an increase of specific enzymes in the cell induced by
the drug. This phenomenon is referred to as "enzyme induction"1 and
will be an important medical field of the future. An example of enzyme
induction in man is the observation that barbiturates accelerate the
metabolism of dicoumarin anticoagulants. A patient receiving dicoum-
eral has a decreased level of anticoagulant activity when barbiturates
are given. This effect requires that the dosage of dicoumeral be in-
creased to achieve an adequate level of anticoagulation. Serious toxicity
results if the enzyme stimulator (e.g., phenobarbital) is withdrawn and
the anticoagulant is continued at the same dose that was used when
phenobarbital was being given.
10 Weinstein & Dalton, Host Determinants of Response to Antimicrobial Agents, 279
N. ENO. J. MED. 580 (1968).
11 Conney, Pharmacological Implications oj Microsomal Enzyme Induction, 19 PHARM.
REV. 317 (1967).
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ALTERATION OF EXTERNAL ENVIRONMENT
An occult, acquired disease is frequently manifested by a change in
the external environment. A common problem in medical practice is
the discovery of cancer in a bone at the time of accidental fracture of
the bone. A primary or metastatic tumor of the bone can reach an
enormous size before the weakened framework spontaneously breaks.
However, trauma may fracture the bone at the tumor site before the
disease is apparent and problems of legal responsibility for the frac-
ture, and, occasionally, questions of causation of a cancer by the
trauma are raised. Single, isolated trauma is never a cause of cancer,
but repeated trauma to the same area can be a cause of cancer. A
nevus, the common pigmented mole, may become malignant (malignant
melanoma) by repeated injury to the surface of the mole. For this rea-
son, all moles located over pressure areas of the body should be re-
moved. Repeated and intense exposure to sunlight, a type of trauma,
is a cause of skin cancer. It is rare to see a basal cell carcinoma of the
skin in any area of the body that is covered commonly from the sun.
A common medico-legal problem is the effect of external environ-
mental change on the cardiovascular system. The relation of such fac-
tors as occupational stress, or emotional alteration to the occurrence of
a myocardial infarction (heart attack) is unclear. Evidence supporting
a causal relationship is confused by the multiple factors of racial inci-
dence, inherited familial predisposition, dietary and exercise habits,
and coexisting disease. In addition, the concept of prolonged asympto-
matic disease is illustrated strikingly in the majority of these patients:
postmortem studies invariably show a severe degree of atherosclerosis
in multiple arteries of the body, indicative of a generalized disease of
long duration.
SUMMARY
A change in the internal or external environment of the patient may
cause a heretofore unrecognized asymptomatic disease to become overt
and symptomatic. The disease may be inherited or acquired but in
both cases the physician and patient are unaware of its presence until
an environmental change occurs.
Limitations imposed on medical science by the sensitivity of current
1969]
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diagnostic methodology and the biological law of organ reserve capac-
ity make it difficult to diagnose disease in the asymptomatic stage. The
medico-legal assumption that an alteration of environment, such as
drugs or trauma, has a simple causal relation to the resultant reaction
should be re-evaluated when the reaction represents an unmasking of
a hidden disease and is dependent upon the presence of the asympto-
matic disease.
